Iovance Biotherapeutics I... (IOVA)
6.20
-0.05 (-0.80%)
At close: Jan 28, 2025, 2:16 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Net Income | -444.04M | -395.89M | -342.25M | -259.58M | -197.56M | -123.58M | -92.06M | -52.89M | -27.66M | -12.03M | -25.38M | -3.31M | -25.69M | -1.61M | -15.77K | -57.14K |
| Depreciation & Amortization | 33.13M | 21.14M | 13.98M | 1.14M | 1.17M | 956.00K | 952.00K | 978.00K | 999.00K | 88.22K | 7.09K | 6.21K | 2.70K | 58.60K | 1.33K | 1.33K |
| Stock-Based Compensation | 62.63M | 84.02M | 69.77M | 40.89M | 24.28M | 20.03M | 11.97M | 18.90M | 8.52M | 3.81M | 19.68M | 3.33M | n/a | n/a | n/a | n/a |
| Other Working Capital | -1.08M | -8.78M | 17.58M | 5.95M | -2.70M | 1.16M | 47.00K | 668.00K | -211.00K | -145.65K | 279.30K | 3.57M | -21.42K | -8.30K | n/a | -1.50K |
| Other Non-Cash Items | -3.54M | 871.00K | 6.01M | 7.57M | 6.62M | -1.32M | 19.00K | -74.00K | 8.52M | 3.81M | 21.98M | -3.42M | 19.14M | 906.59K | n/a | n/a |
| Deferred Income Tax | -3.48M | n/a | n/a | 1.86M | -3.40M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -6.52M | -2.89M | 24.55M | 2.98M | 10.01M | 2.67M | 416.00K | 418.00K | -243.00K | -500.59K | -264.26K | 4.48M | 359.85K | 22.00K | -8 | -1.50K |
| Operating Cash Flow | -361.82M | -292.76M | -227.94M | -205.13M | -158.89M | -101.25M | -78.71M | -32.67M | -18.38M | -8.63M | -3.66M | -2.24M | -6.19M | -620.80K | -14.45K | -57.30K |
| Capital Expenditures | -22.29M | -20.43M | -37.57M | -46.79M | -6.92M | -1.20M | -1.03M | -1.52M | -1.14M | -1.59M | -12.71K | n/a | -31.05K | n/a | n/a | n/a |
| Acquisitions | -212.63M | -276.88M | -37.71M | 271.06M | -96.94M | n/a | n/a | n/a | 19.95M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -205.90M | -245.82M | -725.21M | -947.66M | -417.66M | -426.08M | n/a | -110.25M | -160.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 285.58M | 522.70M | 762.91M | 676.60M | 514.60M | 41.00M | 59.70M | 120.66M | 70.60M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 276.88M | 37.71M | -271.06M | 96.94M | -385.08M | 59.70M | 10.41M | -19.95M | n/a | -12.71K | n/a | -50.00K | n/a | n/a | n/a |
| Investing Cash Flow | -155.24M | 256.45M | 132.00K | -317.85M | 90.03M | -386.28M | 58.68M | 8.89M | -91.15M | -1.59M | -12.71K | n/a | -81.05K | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | 1.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 311.00K | 1.48M | 4.62M | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | -312.00K | n/a | -1.25M | -642.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -49.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -322.00K | 648.00K | 35.11M | 9.38M | 6.13M | 25.49M | 58.69M | 146.36M | 9.96M | 3.22M | 15.91M | n/a | n/a | -4.98K | 19.80K | 2.50K |
| Financial Cash Flow | 462.96M | 190.15M | 239.27M | 576.42M | 6.13M | 424.31M | 58.69M | 96.90M | 78.27M | 35.46M | 23.35M | 1.73M | 5.49M | 1.91M | 19.80K | n/a |
| Net Cash Flow | -56.84M | 153.85M | 11.46M | 53.44M | -62.73M | -63.22M | 38.66M | 73.13M | -31.27M | 25.24M | 19.67M | -510.22K | -782.25K | 1.28M | 5.35K | -57.30K |
| Free Cash Flow | -384.11M | -313.18M | -265.51M | -251.93M | -165.81M | -102.45M | -79.74M | -34.19M | -19.52M | -10.23M | -3.67M | -2.24M | -6.22M | -620.80K | -14.45K | -57.30K |